Health News
- U Of L Gets Patents For New Cancer Treatments, Spinal Cord Treatments And A New Bone Graft Product
The University of Louisville Research Foundation has recently been awarded patents for improved cancer treatments, a new bone graft material, and therapies for spinal cord damage, and two of the inventions are already licensed and will soon be utilized...
- Lung Cancer Gets Much Less Research Funding Than Other Cancers, But Is Deadlier, Especially In Kentucky
Lung cancer takes more lives annually than breast, prostate, and colon cancers combined, but the disease "generally doesn't get the public attention or research dollars in proportion to its lethality," Arielle Densen, co-founder of Lung Cancer Free...
- Kentucky Gets A $7 Million Grant To Improve Survival Rates For Lung Cancer, In Which It Leads The Nation
The University of Kentucky, the University of Louisville and the Lung Cancer Alliance have joined in a unique project called Kentucky LEADS (Lung Cancer, Education, Awareness, Detection, Survivorship) Collaborative to assess new approaches for identifying...
- Markey Cancer Center At Uk Gets National Cancer Institute Designation, Opening Up New Treatment Options For Patients
The University of Kentucky annouced Friday that its Markey Cancer Center has earned a prestigious National Cancer Institute designation. With this designation, the center becomes one of 68 in the U.S., and the only one in Kentucky, with special access...
- Breaking Down The Myths Of Clinical Trials
by Judy Bosley RN, BSN, Oncology Research Nurse Manager The Alvin and Lois Lapidus Cancer Institute Hearing the diagnosis of cancer can be a life changing event. The diagnosis can create many different feelings, anger, disbelief, sadness and shock. Once...
Health News
New cancer treatment for late stage lung cancer that was developed at UK is approved for clinical trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says.
The medical device, called "Exatherm Total Body Hyperthermia System (Exatherm-TBH)," is used in a treatment that heats a patient's blood to about 107 degrees. The procedure takes approximately four hours under general anesthetic.
?Cancer cells are more susceptible to damage from heat than normal tissue, so the development of a safe method to deliver heat throughout the body may be a key step forward for advanced lung cancer patients,? Jeremiah Martin, surgical director of the UK Markey Cancer Center?s Multidisciplinary Lung Cancer Clinic and part of the research team, said in the release.
Because this treatment "attacks cancer cells throughout the body all at once, the research team hopes the project will lead to a new and safe method for treating patients whose cancer has metastasized through the body," says the release.
To learn more or to find out if you are eligible for this study visit UKClinicalResearch.com or call 859-323-6494.
The device was developed through a public-private partnership with Exatherm Inc. and the project is supported by a grant from the National Institutes of Health.
The medical device, called "Exatherm Total Body Hyperthermia System (Exatherm-TBH)," is used in a treatment that heats a patient's blood to about 107 degrees. The procedure takes approximately four hours under general anesthetic.
?Cancer cells are more susceptible to damage from heat than normal tissue, so the development of a safe method to deliver heat throughout the body may be a key step forward for advanced lung cancer patients,? Jeremiah Martin, surgical director of the UK Markey Cancer Center?s Multidisciplinary Lung Cancer Clinic and part of the research team, said in the release.
Because this treatment "attacks cancer cells throughout the body all at once, the research team hopes the project will lead to a new and safe method for treating patients whose cancer has metastasized through the body," says the release.
To learn more or to find out if you are eligible for this study visit UKClinicalResearch.com or call 859-323-6494.
The device was developed through a public-private partnership with Exatherm Inc. and the project is supported by a grant from the National Institutes of Health.
- U Of L Gets Patents For New Cancer Treatments, Spinal Cord Treatments And A New Bone Graft Product
The University of Louisville Research Foundation has recently been awarded patents for improved cancer treatments, a new bone graft material, and therapies for spinal cord damage, and two of the inventions are already licensed and will soon be utilized...
- Lung Cancer Gets Much Less Research Funding Than Other Cancers, But Is Deadlier, Especially In Kentucky
Lung cancer takes more lives annually than breast, prostate, and colon cancers combined, but the disease "generally doesn't get the public attention or research dollars in proportion to its lethality," Arielle Densen, co-founder of Lung Cancer Free...
- Kentucky Gets A $7 Million Grant To Improve Survival Rates For Lung Cancer, In Which It Leads The Nation
The University of Kentucky, the University of Louisville and the Lung Cancer Alliance have joined in a unique project called Kentucky LEADS (Lung Cancer, Education, Awareness, Detection, Survivorship) Collaborative to assess new approaches for identifying...
- Markey Cancer Center At Uk Gets National Cancer Institute Designation, Opening Up New Treatment Options For Patients
The University of Kentucky annouced Friday that its Markey Cancer Center has earned a prestigious National Cancer Institute designation. With this designation, the center becomes one of 68 in the U.S., and the only one in Kentucky, with special access...
- Breaking Down The Myths Of Clinical Trials
by Judy Bosley RN, BSN, Oncology Research Nurse Manager The Alvin and Lois Lapidus Cancer Institute Hearing the diagnosis of cancer can be a life changing event. The diagnosis can create many different feelings, anger, disbelief, sadness and shock. Once...